Utility of MALDI-TOF MS as a new tool for Streptococcus pneumoniae serotyping

PLoS One. 2019 Feb 12;14(2):e0212022. doi: 10.1371/journal.pone.0212022. eCollection 2019.

Abstract

Nowadays, more than 95 different Streptococcus pneumoniae serotypes are known, being less than one third responsible for the majority of severe pneumococcal infections. After the introduction of conjugate vaccines, a change in the epidemiology of the serotypes causing invasive pneumococcal disease has been observed making the surveillance of circulating serotypes especially relevant. Some recent studies have used matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) technology to identify the most frequent pneumococcal serotypes that cause invasive disease. The objectives of this study were to evaluate the efficacy of previously described discriminatory peaks determined by MALDI-TOF MS for the identification of serotypes 6B, 19F, 19A and 35B using reference and clinical isolates and to try to identify other discriminatory peaks for serotypes 11A, 19F and 19A using transformed pneumococcal strains. Most of the proposed peaks defined in the literature for the identification of serotypes 6B, 19F, 19A, 35B were not found in the spectra of the 10 reference isolates nor in those of the 60 clinical isolates tested corresponding to these four serotypes. The analysis and comparison of the mass spectra of genetically modified pneumococci (transformed strains) did not allow the establishment of new discriminatory peaks for serotypes 11A, 19F, and 19A. MALDI-TOF MS in the usual range of 2,000 to 20,000 m/z did not prove to be a valid technique for direct S. pneumoniae serotyping.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Typing Techniques
  • Humans
  • Molecular Typing
  • Pneumococcal Infections / prevention & control
  • Pneumococcal Infections / virology*
  • Pneumococcal Vaccines / immunology
  • Serotyping
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Streptococcus pneumoniae / classification*
  • Streptococcus pneumoniae / genetics
  • Vaccines, Conjugate / immunology

Substances

  • Pneumococcal Vaccines
  • Vaccines, Conjugate

Grants and funding

This work was funded in part by a grant of the Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), CB06/06/0056 and CB06/06/0003. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.